StreetInsider.com News Articles

Form 4 MYRIAD GENETICS INC For: Jun 23 Filed by: Skovronsky Daniel

Tue, 23 Jun 2026 16:25:00 -0400

si-local-file:///var/storage/secattach/20260623/26679810.html

Form 4 MYRIAD GENETICS INC For: Jun 23 Filed by: Skovronsky Daniel

Tue, 23 Jun 2026 16:25:00 -0400

si-local-file:///var/storage/secattach/20260623/26679810.html

Myriad Genetics expands Precise MRD cancer test to three tumor types

Tue, 23 Jun 2026 09:05:55 -0400

Myriad Genetics (NASDAQ: MYGN) announced the expanded availability of its Precise MRD test to patients with breast, colorectal, and renal cancers, according to a company press release. More than 6 million people in the U.S. are living with these cancers, according to the National Cancer Institute.

Precise MRD is a whole-genome sequencing-based assay that tracks up to 1,000 patient-specific variants to measure circulating tumor DNA (ctDNA). The test is designed for use at multiple points in cancer care, including neoadjuvant monitoring, post-surgical assessment, and long-term surveillance.

Alongside the expansion, Myriad published results from the prospective, multi-center MONITOR-Breast study in Future Oncology. The

Myriad Genetics Expands Availability of Precise MRD™ for Colorectal, Renal and Breast Cancers, Supported by New Publication

Tue, 23 Jun 2026 09:05:00 -0400

Publication of MONITOR-Breast study marks latest milestone for clinical validity of Precise MRD

SALT LAKE CITY, June 23, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announces expanded availability of Precise MRD™, broadening availability to patients undergoing treatment and surveillance for breast, colorectal and renal cancers. More than 6 million individuals are living with these cancers in the U.S., representing a significant expansion in access to Myriad’s ultrasensitive Precise MRD test¹.

Precise MRD is a next-generation, ultrasensitive, whole-genome sequencing-based assay that generates a personalized

Myriad Genetics Expands Availability of Precise MRD™ for Colorectal, Renal and Breast Cancers, Supported by New Publication

Tue, 23 Jun 2026 09:05:00 -0400

Publication of MONITOR-Breast study marks latest milestone for clinical validity of Precise MRD

Precise MRD is a next-generation, ultrasensitive, whole-genome sequencing-based assay that generates a personalized

Myriad Genetics board member Skovronsky resigns

Tue, 23 Jun 2026 08:36:07 -0400

Daniel M. Skovronsky, M.D., Ph.D., a member of the board of directors of Myriad Genetics (NASDAQ: MYGN), resigned from his position effective June 17, 2026.

According to a company statement, Skovronsky's departure was not the result of any disagreement with the company or any matter relating to its operations, policies, or practices.

Myriad Genetics board member Skovronsky resigns

Tue, 23 Jun 2026 08:36:07 -0400

Daniel M. Skovronsky, M.D., Ph.D., a member of the board of directors of Myriad Genetics (NASDAQ: MYGN), resigned from his position effective June 17, 2026.

According to a company statement, Skovronsky's departure was not the result of any disagreement with the company or any matter relating to its operations, policies, or practices.

Form 8-K MYRIAD GENETICS INC For: Jun 17

Tue, 23 Jun 2026 08:32:00 -0400

si-local-file:///var/storage/secattach/20260623/26676500.html

Form 8-K MYRIAD GENETICS INC For: Jun 17

Tue, 23 Jun 2026 08:32:00 -0400

si-local-file:///var/storage/secattach/20260623/26676500.html

Form 4 MYRIAD GENETICS INC For: Jun 11 Filed by: Donnelly Brian J

Fri, 12 Jun 2026 18:06:00 -0400

si-local-file:///var/storage/secattach/20260612/26642379.html

Form 4 MYRIAD GENETICS INC For: Jun 11 Filed by: Donnelly Brian J

Fri, 12 Jun 2026 18:06:00 -0400

si-local-file:///var/storage/secattach/20260612/26642379.html

Form 4 MYRIAD GENETICS INC For: Jun 11 Filed by: Raha Samraat S.

Fri, 12 Jun 2026 18:06:00 -0400

si-local-file:///var/storage/secattach/20260612/26642381.html

Form 4 MYRIAD GENETICS INC For: Jun 11 Filed by: Raha Samraat S.

Fri, 12 Jun 2026 18:06:00 -0400

si-local-file:///var/storage/secattach/20260612/26642381.html

TD Cowen notes short interest shifts in life science tools stocks

Wed, 10 Jun 2026 10:50:16 -0400